Resistance mechanism of imatinib therapy in gastrointestinal stromal tumors / 国际外科学杂志
International Journal of Surgery
;
(12): 754-756, 2008.
Artículo
en Chino
| WPRIM
| ID: wpr-397648
ABSTRACT
Imatinib,a small-molecule kinase inhibitor,has proven useful in the treatment of recurrent or metastatic gastrointestinal stromal tumors ,However,resistance to imatinib is a more and more serious problem.This review summarizes the existing knowledge of the imatinib resistance mechanism in gastrointestinal stromal tumors and describes the treatment directions in further.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
International Journal of Surgery
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS